Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

BUY
$181.58 - $368.0 $12,347 - $25,024
68 Added 6.42%
1,128 $244,000
Q1 2022

May 09, 2022

BUY
$303.87 - $423.8 $37,376 - $52,127
123 Added 13.13%
1,060 $370,000
Q4 2021

Feb 09, 2022

SELL
$347.28 - $421.83 $17,016 - $20,669
-49 Reduced 4.97%
937 $356,000
Q3 2021

Nov 09, 2021

SELL
$405.61 - $524.84 $43,805 - $56,682
-108 Reduced 9.87%
986 $400,000
Q2 2021

Aug 06, 2021

SELL
$372.84 - $481.5 $6,338 - $8,185
-17 Reduced 1.53%
1,094 $518,000
Q1 2021

May 10, 2021

BUY
$361.28 - $504.76 $1,806 - $2,523
5 Added 0.45%
1,111 $427,000
Q4 2020

Feb 12, 2021

SELL
$292.7 - $370.96 $91,907 - $116,481
-314 Reduced 22.11%
1,106 $409,000
Q3 2020

Nov 10, 2020

BUY
$268.51 - $400.74 $39,739 - $59,309
148 Added 11.64%
1,420 $439,000
Q2 2020

Aug 12, 2020

BUY
$256.46 - $373.01 $12,822 - $18,650
50 Added 4.09%
1,272 $471,000
Q1 2020

May 07, 2020

BUY
$209.2 - $335.53 $8,368 - $13,421
40 Added 3.38%
1,222 $334,000
Q4 2019

Feb 07, 2020

BUY
$288.29 - $335.49 $36,612 - $42,607
127 Added 12.04%
1,182 $392,000
Q3 2019

Nov 06, 2019

BUY
$266.84 - $378.23 $1,867 - $2,647
7 Added 0.67%
1,055 $321,000
Q2 2019

Aug 06, 2019

BUY
$300.59 - $368.15 $30,058 - $36,815
100 Added 10.55%
1,048 $386,000
Q1 2019

May 09, 2019

SELL
$272.57 - $321.18 $15,809 - $18,628
-58 Reduced 5.77%
948 $295,000
Q4 2018

Feb 07, 2019

SELL
$272.46 - $366.54 $40,051 - $53,881
-147 Reduced 12.75%
1,006 $302,000
Q3 2018

Oct 29, 2018

BUY
$279.04 - $367.06 $18,695 - $24,593
67 Added 6.17%
1,153 $423,000
Q2 2018

Aug 06, 2018

BUY
$228.17 - $292.07 $23,957 - $30,667
105 Added 10.7%
1,086 $303,000
Q1 2018

May 01, 2018

BUY
$209.54 - $253.91 $10,267 - $12,441
49 Added 5.26%
981 $232,000
Q4 2017

Feb 02, 2018

BUY
$202.23 - $230.03 $188,478 - $214,387
932
932 $204,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Checchi Capital Advisers, LLC Portfolio

Follow Checchi Capital Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Checchi Capital Advisers, LLC with notifications on news.